Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience

Real-world predictors of the treatment efficacy of immune checkpoint inhibitors for hepatocellular carcinoma (HCC) are unknown. This retrospective study enrolled 87 consecutive patients with unresectable HCC from May 2017 to December 2019 at two hospitals. Of the 87 patients, 7, 9, 60, and 11 patien...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Cancer Res
Egile Nagusiak: Hsu, Wei-Fan, Chuang, Po-Heng, Chen, Cheng-Kuo, Wang, Hung-Wei, Tsai, Ming-Hung, Su, Wen-Pang, Chen, Hung-Yao, Yang, Chi-Ying, Lin, Chun-Che, Huang, Guan-Tarn, Lin, Jaw-Town, Lai, Hsueh-Chou, Peng, Cheng-Yuan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: e-Century Publishing Corporation 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783753/
https://ncbi.nlm.nih.gov/pubmed/33415018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak